(Q37858626)

24 August 2017

1 reference

title

Systematic reviews of sublingual immunotherapy (SLIT). (English)

1 reference

24 August 2017

1 reference

1 reference

S Radulovic

1

1 reference

24 August 2017

D Wilson

series ordinal

2

1 reference

24 August 2017

M Calderon

series ordinal

3

1 reference

24 August 2017

Stephen Durham

series ordinal

4

1 reference

24 August 2017

publication date

28 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

66

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

740-752

1 reference

Towards evidence-based medicine in specific grass pollen immunotherapy

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Recommendations for appropriate sublingual immunotherapy clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Sublingual immunotherapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

Injection allergen immunotherapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02583.X

10.1111/J.1398-9995.2011.02583.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference